Helen Sabzevari - 27 Jan 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
27 Jan 2023
Net transactions value
+$40,000
Form type
4
Filing time
30 Jan 2023, 18:23:01 UTC
Previous filing
06 Jan 2023
Next filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Purchase $40,000 +22,857 +2.5% $1.75 937,613 27 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price.